Journal of General Internal Medicine

, Volume 21, Issue 11, pp 1178–1183

Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes

  • Ian M. Kronish
  • Nina Rieckmann
  • Ethan A. Halm
  • Daichi Shimbo
  • David Vorchheimer
  • Donald C. Haas
  • Karina W. Davidson
Original Articles

Abstract

BACKGROUND: The persistence of depressive symptoms after hospitalization is a strong risk factor for mortality after acute coronary syndromes (ACS). Poor adherence to secondary prevention behaviors may be a mediator of the relationship between depression and increased mortality.

OBJECTIVE: To determine whether rates of adherence to risk reducing behaviors were affected by depressive status during hospitalization and 3 months later.

DESIGN: Prospective observational cohort study.

SETTING: Three university hospitals.

PARTICIPANTS: Five hundred and sixty patients were enrolled within 7 days after ACS. Of these, 492 (88%) patients completed 3-month follow-up.

MEASUREMENTS: We used the Beck Depression Inventory (BDI) to assess depressive symptoms in the hospital and 3 months after discharge. We assessed adherence to 5 risk-reducing behaviors by patient self-report at 3 months. We used χ2 analysis to compare differences in adherence among 3 groups: persistently nondepressed (BDI<10 at hospitalization and 3 months); remittent depressed (BDI ≥10 at hospitalization; <10 at 3 months); and persistently depressed patients (BDI ≥10 at hospitalization and 3 months).

RESULTS: Compared with persistently nondepressed, persistently depressed patients reported lower rates of adherence to quitting smoking (adjusted odds ratio [OR] 0.23, 95% confidence interval [95% CI] 0.05 to 0.97), taking medications (adjusted OR 0.50, 95% CI 0.27 to 0.95), exercising (adjusted OR 0.57, 95% CI 0.34 to 0.95), and attending cardiac rehabilitation (adjusted OR 0.5, 95% CI 0.27 to 0.91). There were no significant differences between remittent depressed and persistently nondepressed patients.

CONCLUSIONS: Persistently depressed patients were less likely to adhere to behaviors that reduce the risk of recurrent ACS. Differences in adherence to these behaviors may explain in part why depression predicts mortality after ACS.

Key Words

cardiovascular diseases depression medication adherence prevention self care 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lane D, Carroll D, Ring C, Beevers DG, Lip GY. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol. 2002;7:11–21.PubMedCrossRefGoogle Scholar
  2. 2.
    Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160:1354–60.PubMedCrossRefGoogle Scholar
  3. 3.
    Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996;93:1976–80.Google Scholar
  4. 4.
    Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999–1005.PubMedGoogle Scholar
  5. 5.
    Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88:337–41.PubMedCrossRefGoogle Scholar
  6. 6.
    Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomat Med. 2004;66:802–13.CrossRefGoogle Scholar
  7. 7.
    Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45:637–51.PubMedCrossRefGoogle Scholar
  8. 8.
    Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMedGoogle Scholar
  9. 9.
    McKellar JD, Humphreys K, Piette JD. Depression increases diabetes symptoms by complicating patients’ self-care adherence. Diabetes Educ. 2004;30:485–92.PubMedGoogle Scholar
  10. 10.
    Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25:246–52.PubMedCrossRefGoogle Scholar
  11. 11.
    DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Park H, Hong Y, Lee H, Ha E, Sung Y. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol. 2004;57:978–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154–60.PubMedCrossRefGoogle Scholar
  14. 14.
    Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens. 2005;23:611–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394–402.PubMedCrossRefGoogle Scholar
  16. 16.
    Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosomat Res. 2001;51:497–501.CrossRefGoogle Scholar
  18. 18.
    Grace SL, Abbey SE, Pinto R, Shnek ZM, Irvine J, Stewart DE. Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation. Psychosomat Med. 2005;67:52–58.CrossRefGoogle Scholar
  19. 19.
    Brummett BH, Babyak MA, Siegler IC, Mark DB, Williams RB, Barefoot JC. Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol. 2003;92:529–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178:339–44.PubMedCrossRefGoogle Scholar
  21. 21.
    Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosomat Res. 2002;53:897–902.CrossRefGoogle Scholar
  23. 23.
    Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosomat Med. 2004;66:305–15.CrossRefGoogle Scholar
  24. 24.
    Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989;149:1785–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Lauzon C, Beck CA, Huynh T, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. Can Med Assoc J. 2003;168:547–52.Google Scholar
  26. 26.
    Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049–53.PubMedCrossRefGoogle Scholar
  27. 27.
    Bush DE, Ziegelstein RC, Patel UV, et al. Post-myocardial infarction depression. Evid Rep Tech Assess [Summ]. 2005;123:1–8.Google Scholar
  28. 28.
    Beck AT, Steer RA. Manual for the Beck Depression Inventory. San Antonto, TX: Psychological Corporation; 1993.Google Scholar
  29. 29.
    Strik JJ, Hong A, Lousberg R, Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics. 2001;42:423–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRefGoogle Scholar
  31. 31.
    Pignone M, Rihal CS, Bazian Ltd. Secondary prevention of ischaemic cardiac events. Clin Evid. 2004;12:193–235.Google Scholar
  32. 32.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.PubMedCrossRefGoogle Scholar
  33. 33.
    Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother. 2002;36:1532–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Morgado A, Raoux N, Jourdain G, Lecrubier Y, Widlocher D. Over-reporting of maladjustment by depressed subjects: findings from retesting after recovery. Soc Psychiatry Psychiatr Epidemiol. 1991;26:68–74.PubMedCrossRefGoogle Scholar
  35. 35.
    Watson D, Pennebaker JW. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol Rev. 1989;96:234–54.PubMedCrossRefGoogle Scholar
  36. 36.
    EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II euro heart survey programme. Eur Heart J. 2001;22:554–72.CrossRefGoogle Scholar
  37. 37.
    Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: An Ongoing Prospective, Observational Study. Am J Med. 2004;117:73–81.PubMedCrossRefGoogle Scholar
  38. 38.
    DiMatteo MR, Giordain PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.PubMedCrossRefGoogle Scholar
  39. 39.
    Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336:542–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther. 2004;42:409–22.PubMedCrossRefGoogle Scholar
  41. 41.
    Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Katon WJ, Von Korff M, Lin EH, et al. The pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry. 2004;61:1042–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1998;129:613–21.PubMedGoogle Scholar
  44. 44.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(suppl 1):S4-S36.CrossRefGoogle Scholar
  45. 45.
    Glassman AH, O’Connor CM, Califf RM. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease (ENRICHD) randomized trial. JAMA. 2004;289:3106–16.Google Scholar
  47. 47.
    Newman S. Engaging patients in managing their cardiovascular health. Heart. 2004;90(suppl 4):iv9-iv13, iv39–iv40.PubMedCrossRefGoogle Scholar

Copyright information

© the Society of General Internal Medicine 2006

Authors and Affiliations

  • Ian M. Kronish
    • 1
  • Nina Rieckmann
    • 2
  • Ethan A. Halm
    • 1
  • Daichi Shimbo
    • 4
  • David Vorchheimer
    • 3
  • Donald C. Haas
    • 3
  • Karina W. Davidson
    • 4
    • 3
  1. 1.Division of General Internal MedicineMount Sinai School of MedicineNew YorkUSA
  2. 2.Department of PsychiatryMount Sinai School of MedicineNew YorkUSA
  3. 3.Cardiovascular InstituteMount Sinai School of MedicineNew YorkUSA
  4. 4.Department of MedicineColumbia University Medical CenterNew York

Personalised recommendations